Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
5.05
-0.10 (-1.94%)
Feb 4, 2026, 4:00 PM EST - Market closed
Climb Bio Employees
As of December 31, 2024, Climb Bio had 18 total employees, including 17 full-time and 1 part-time employees. The number of employees increased by 7 or 63.64% compared to the previous year.
Employees
18
Change (1Y)
7
Growth (1Y)
63.64%
Revenue / Employee
n/a
Profits / Employee
-$2,819,500
Market Cap
241.11M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 18 | 7 | 63.64% | 17 | 1 |
| Dec 31, 2023 | 11 | -32 | -74.42% | 9 | 2 |
| Dec 31, 2022 | 43 | 12 | 38.71% | 30 | 13 |
| Sep 30, 2022 | 43 | 15 | 53.57% | 43 | 0 |
| Jun 30, 2022 | 41 | 16 | 64.00% | 41 | 0 |
| Mar 31, 2022 | 37 | 15 | 68.18% | 37 | 0 |
| Dec 31, 2021 | 31 | 9 | 40.91% | 19 | 12 |
| Sep 30, 2021 | 28 | - | - | 28 | 0 |
| Jun 30, 2021 | 25 | - | - | 25 | 0 |
| Mar 31, 2021 | 22 | - | - | 13 | 9 |
Related Stocks
| Company Name | Employees |
|---|---|
| Protalix BioTherapeutics | 213 |
| Cabaletta Bio | 151 |
| Nautilus Biotechnology | 124 |
| Heron Therapeutics | 122 |
| OmniAb | 114 |
| MediWound | 111 |
| Enlivex Therapeutics | 71 |
| Shattuck Labs | 44 |
CLYM News
- 1 hour ago - Climb Bio to Present at Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Climb Bio Announces Pipeline Progress and Strategic Priorities for 2026 - GlobeNewsWire
- 2 months ago - Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 months ago - Climb Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates - GlobeNewsWire
- 3 months ago - Climb Bio to Present at Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Climb Bio Names Adam Villa as SVP, Technical Operations and Ashley Jones as SVP, People & Workforce Strategy - GlobeNewsWire
- 3 months ago - Climb Bio to Present Data at American Society of Nephrology (ASN) Kidney Week 2025 - GlobeNewsWire
- 4 months ago - Climb Bio Appoints Susan Altschuller, Ph.D., MBA as Chief Financial Officer - GlobeNewsWire